budesonide nasal spray (CF010/CF052)
/ Changfeng Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 30, 2026
CF PharmTech’s Budesonide Nasal Spray Application Accepted by China’s NMPA
(TipRanks)
- "CF PharmTech, Inc. has had its marketing authorization application for a budesonide nasal spray accepted by China’s National Medical Products Administration, covering indications such as seasonal and perennial allergic and non-allergic rhinitis as well as prevention and treatment of nasal polyps in patients aged six and above."
China filing • Allergic Rhinitis • Nasal Polyps
1 to 1
Of
1
Go to page
1